Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Antiseizure medications
10 evidence topics · 9 sources
Consensus guideline: neurology referral and antiseizure medication monitoring
“Refer to neurologist for seizures and spells suspicious for seizures, with follow-up every 6 months if treated with an anticonvulsant. It is difficult to differentiate between a non-epileptic Rett spell and a seizure (both may be present).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“If the individual’s weight fluctuates (more than 10%–20%), request the neurologist to consider adjusting anticonvulsant doses accordingly. Laboratory follow-up as needed for use of antiseizure medications.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“but there have been no randomised controlled trials of specific anticonvulsants for RTT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Natural History Study: remission and medication withdrawal
“Although 248 of those with classic Rett syndrome and a history of seizures were in terminal remission at last contact, only 74 (12% of those with a history of epilepsy) were seizure free and off anti-seizure medication.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Notably, persistent drug resistant epilepsy without remission is not the most common pattern, only affecting 16% of those with classic Rett syndrome, a figure less than half that of the Italian and Australian studies.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Antiseizure drug selection: comparative evidence and adverse-effect considerations
“Although cases and retrospective studies document efficacy of specific medications in Rett syndrome, no systematic study has demonstrated superiority of a specific medication or class of medications to treat epilepsy in Rett syndrome” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“No specific medications are contraindicated in Rett syndrome; however, the issue of bone health is an important consideration when prescribing anti-seizure drugs.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“In summary, when seizures are concluded to be epileptic in origin and anti-seizure drugs are initiated, the side effect profiles of medications should be considered carefully, and medications, which can cause behavioural issues (e.g. levetiracetam), anorexia and nephrolithiasis (e.g. topiramate), QT interval prolongation (e.g. felbamate), or marked sedation (e.g. benzodiazepines), should be used with caution.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Review: lack of comparative studies and non-pharmacological options for refractory epilepsy
“There are problems in evaluating the treatment efficiency of AED due to the general lack of comparative studies and the number of different AED used in monotherapy or combination treatment in RTT.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Due to limited experience of epilepsy treatment in RTT, no definite recommendation regarding anticonvulsants is currently available.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The ketogenic diet and vagal nerve stimulation have been reported to be effective treatment options in some refractory RTT cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Antiseizure medications prescribed in a US electronic health record cohort
| Antiseizure medication | Participants with epilepsy, n (%) (N = 59) |
|---|---|
| Levetiracetam | “27 (45.8%)”View highlighted excerpt for this quote |
| Clonazepam | “22 (37.3%)”View highlighted excerpt for this quote |
| Oxcarbazepine | “18 (30.5%)”View highlighted excerpt for this quote |
| Lamotrigine | “15 (25.4%)”View highlighted excerpt for this quote |
| Valproate or valproic acid | “15 (25.4%)”View highlighted excerpt for this quote |
| Topiramate | “10 (16.9%)”View highlighted excerpt for this quote |
| Lacosamide | “7 (11.9%)”View highlighted excerpt for this quote |
Drug-resistant epilepsy and absence of first-line recommendations
“While AEDs are effective therapy, either as monotherapy or in combination, for many individuals who have seizures in RTT, 20–40% experience drug-resistant epilepsy” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Due to the non-localized nature of epilepsy in RTT, unlike individuals with other types epilepsy (i.e., focal onset epilepsy), surgical treatments are generally not effective for drug-resistant epilepsy in RTT” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cannabidiol for drug-resistant epilepsy: Italian multicenter cohort
“We enrolled 27 subjects (26 females), carrying a MECP2 genetic variant (14 subjects, 51.9%) or a CDKL5 genetic variant (13 subjects, 48.1%).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Although not reaching a significant statistical effect, CBD reduced the incidence of seizures with respect to the baseline in 18/27 (66.6%) subjects, with 7 (25.9%) showing a seizure reduction >75%, and 11 (40.7%) >50%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“The most relevant adverse events were somnolence seen in 3 subjects, irritability/agitation in 2 subjects, loss of appetite in 2 subjects, and insomnia in 1 individual.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cannabidiol as adjunctive therapy: French single-center cohort
“In our cohort, 26 patients had associated epilepsy (26/46 [56%]), and 10/26 (38%) were treated with CBD, in combination with clobazam in 50% of cases.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“CBD reduced the incidence of seizures in seven out of 10 patients (70%) with one seizure‐free patient, two patients with a reduction of seizures of more than 75%, and four patients with a decrease of more than 50%.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Rescue therapy: diazepam nasal spray for seizure clusters
“Age- and weight-based doses of diazepam nasal spray (5–20 mg) were administered to patients (aged 6–65 years) for seizure clusters.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“All caregivers felt diazepam nasal spray was very/extremely easy to use; 63.6% were able to return to normal activities within an hour of administration.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Diazepam nasal spray has safety and effectiveness profiles consistent with the full study population and was easy to use.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Trofinetide with concomitant antiseizure medication
“The most frequently used concomitant medications in the trofinetide and placebo groups were antiseizure medication (64.5% and 72.3%, respectively) and drugs for constipation (60.2% and 70.2%)” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Patient history of seizures should be taken prior to initiating trofinetide, if possible” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“the majority will not experience changes in seizures, while the minority may experience improvement or worsening during treatment, depending on the individual patient” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote